Vascular Solutions Inc. (NASDAQ:VASC) shares saw strong trading volume on Thursday . 169,831 shares changed hands during trading, an increase of 22% from the previous session’s volume of 139,331 shares.The stock last traded at $47.07 and had previously closed at $47.34.

Several analysts have recently weighed in on the stock. Canaccord Genuity reiterated a “buy” rating on shares of Vascular Solutions in a research report on Wednesday. Zacks Investment Research upgraded shares of Vascular Solutions from a “hold” rating to a “buy” rating and set a $52.00 target price on the stock in a research report on Thursday, July 28th. TheStreet upgraded shares of Vascular Solutions from a “hold” rating to a “buy” rating in a research report on Monday, July 25th. Piper Jaffray Cos. lifted their price target on shares of Vascular Solutions from $45.00 to $49.00 and gave the company an “overweight” rating in a report on Tuesday, July 26th. Finally, Sidoti downgraded shares of Vascular Solutions from a “buy” rating to a “neutral” rating and set a $47.00 price target for the company. in a report on Tuesday, July 12th. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $47.38.

The stock has a market capitalization of $822.43 million and a PE ratio of 87.07. The stock’s 50-day moving average is $43.55 and its 200 day moving average is $35.77.

Vascular Solutions (NASDAQ:VASC) last announced its quarterly earnings data on Monday, July 25th. The medical device company reported $0.33 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.30 by $0.03. The firm had revenue of $41.20 million for the quarter, compared to analyst estimates of $41.40 million. During the same quarter in the previous year, the company earned $0.29 earnings per share. The company’s quarterly revenue was up 9.7% on a year-over-year basis. On average, analysts predict that Vascular Solutions Inc. will post $1.24 earnings per share for the current fiscal year.

In other news, VP William Rutstein sold 10,011 shares of the firm’s stock in a transaction that occurred on Wednesday, July 27th. The shares were sold at an average price of $46.26, for a total value of $463,108.86. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Howard Root sold 40,000 shares of the firm’s stock in a transaction that occurred on Wednesday, July 27th. The shares were sold at an average price of $45.11, for a total transaction of $1,804,400.00. Following the completion of the sale, the chief executive officer now owns 347,840 shares in the company, valued at $15,691,062.40. The disclosure for this sale can be found here.

A hedge fund recently raised its stake in Vascular Solutions stock. Argent Capital Management LLC increased its position in shares of Vascular Solutions Inc. (NASDAQ:VASC) by 117.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 97,035 shares of the medical device company’s stock after buying an additional 52,400 shares during the period. Argent Capital Management LLC owned 0.56% of Vascular Solutions worth $3,337,000 at the end of the most recent quarter.

Vascular Solutions, Inc is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.